Back to top
more

Pediatrix Medical Group, Inc. (MD)

(Real Time Quote from BATS)

$8.00 USD

8.00
54,894

+0.32 (4.17%)

Updated Jul 25, 2024 10:40 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 33% (83 out of 250)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Tenet Healthcare (THC) Up 126.9% in 6 Months: More Room for Rally?

by Zacks Equity Research

Tenet Healthcare's (THC) strategic measures and cost-controlling efforts are expected to drive its margins, which in turn, might inflate its share price.

Mednax (MD) Up 60.5% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Mednax (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MEDNAX's (MD) Q3 Earnings Meet Estimates, Revenues Miss

by Zacks Equity Research

MEDNAX's (MD) third-quarter results reflect muted revenues and high costs, partly offset by lower interest expense.

Mednax (MD) Lags Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Mednax (MD) delivered earnings and revenue surprises of -7.50% and -13.87%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Mednax (MD) Q3 Earnings Expected to Decline

by Zacks Equity Research

Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why Should You Retain MEDNAX (MD) in Your Portfolio Now?

by Zacks Equity Research

Riding on restructuring as well as cost-cutting initiatives, MEDNAX (MD) holds potential to reap benefits for investors.

MEDNAX Divests Radiology Business to Focus on Core Operations

by Zacks Equity Research

MEDNAX (MD) reaches an agreement with Radiology Partners to sell its MEDNAX Radiology Solutions, which will lower its debt load and restructure its business.

MEDNAX (MD) Catches Eye: Stock Jumps 5.4%

by Zacks Equity Research

MEDNAX (MD) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Why Should You Hold on to Tenet Healthcare (THC) Stock?

by Zacks Equity Research

Riding high on divestitures and cost-reduction, Tenet Healthcare (THC) holds enough potential to reap benefits for yield-seeking investors.

Why Is Mednax (MD) Down 5.3% Since Last Earnings Report?

by Zacks Equity Research

Mednax (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Tenet Healthcare Up 39% in a Year: Further Upside Left?

by Zacks Equity Research

Tenet Healthcare's (THC) strategic measures and cost-controlling efforts are expected to support its margins, which in turn, might perk up its share price.

MEDNAX's (MD) Q2 Earnings Surpass Estimates, Decline Y/Y

by Zacks Equity Research

MEDNAX's (MD) Q2 results reflect lower expenses, offset by soft revenues.

Mednax (MD) Q2 Earnings Top Estimates

by Zacks Equity Research

Mednax (MD) delivered earnings and revenue surprises of 113.33% and -13.83%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Mednax (MD) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Steer Clear of MEDNAX (MD) at Present

by Zacks Equity Research

Pressure from the COVID-19 impact on global economy and lack of solvency make MEDNAX (MD) an unattractive bet.

Community Health to Sell Unit for Streamlining Operations

by Zacks Equity Research

Community Health (CYH) is set to sell hospital units for debt-reduction and business rejig.

New Strong Sell Stocks for June 11th

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

MEDNAX's (MD) Strategic Initiatives to Streamline Operations

by Zacks Equity Research

MEDNAX (MD) declares several transformational activities, which augur well for the long term.

Why Is Mednax (MD) Up 46.5% Since Last Earnings Report?

by Zacks Equity Research

Mednax (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Should You Hold on to Tenet Healthcare (THC) Stock?

by Zacks Equity Research

Despite the recent drag in Tenet Healthcare's (THC) business volumes, the same is expected to bounce back, given its solid fundamentals and the strategic initiatives taken.

Zacks.com headshot

MEDNAX Plunges More Than 42% YTD: Will the Stock Rebound?

by Zacks.com

Even though MEDNAX (MD) endures the COVID-19 impact on global economy, it holds prospects to revive its fortunes with the help of its initiatives and strong fundamentals.

MEDNAX Affiliate Ties Up With CDI to Improve Patient Care

by Zacks Equity Research

MEDNAX's (MD) affiliate Jefferson Radiology collaborates with CDI for providing enhanced healthcare services to the Springfield community.

MEDNAX Divests American Anesthesiology to Avoid Cash Losses

by Zacks Equity Research

MEDNAX (MD) sells its American Anesthesiology to NAPA for portfolio rationalization and averting the negative COVID-19 impact.

MEDNAX's (MD) Earnings Miss Estimates in Q1, Tumble Y/Y

by Zacks Equity Research

MEDNAX's (MD) Q1 results reflect the coronavirus adversities that drained its revenues and volumes.

    Mednax (MD) Lags Q1 Earnings Estimates

    by Zacks Equity Research

    Mednax (MD) delivered earnings and revenue surprises of -23.81% and 1.29%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?